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Abstract
Purpose: To determine the prevalence of spinal dural arteriovenous fistulae (SDAVF) in patients presenting with prominent
vascular flow voids on imaging without other imaging findings suggestive of SDAVF.
Methods: We retrospectively identified patients from January 1, 2005 to March 1, 2012 who underwent spinal angiography
for suspected SDAVF with prominent vascular flow voids on prior imaging. We excluded patients with other major spinal
pathology or other imaging findings of SDAVF including cord hyperintensity, enhancement, or expansion. We calculated the
proportion of patients with positive findings for SDAVF on angiography and evaluated the prevalence of SDAVF for this
finding alone and in correlation with clinical findings.
Results: 18 patients underwent spinal angiography for prominent flow voids on imaging without other spinal pathology or
imaging findings of SDAVF. Three had a SDAVF detected on angiography. The prevalence of SDAVF in this population was
low, only 17% (95% CI 6-39%). All of the patients with positive angiography findings had myelopathy, increasing the
prevalence to 100% if the additional clinical finding of myelopathy was present.
Conclusions: Prominent flow voids without other imaging findings suggestive of SDAVF is poorly predictive of the presence
of a SDAVF, unless myelopathy is present clinically.
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Introduction
Although spinal dural arteriovenous fistulae (SDAVF) account
for approximately 70% of all spinal vascular malformations, they
still remain a relatively rare entity [1,2]. The symptomatology
associated with SDAVF is nonspecific and may mimic much more
common pathologies including degenerative disc disease, radicu-
lopathy, spinal stenosis and peripheral neuropathy [3–6]. Early
detection is key, as prognosis depends on the duration of symptoms
[1]. With its nonspecific clinical presentation, conventional
imaging may be the first to suggest a SDAVF as the causative
pathology. T2 hyperintensity within the cord has been shown to be
100% sensitive for detection of SDAVF[7,8], but may be a later
finding, as it indicates edema and hypoxia which are long-term
sequelae resulting due to venous hypertension from the SDAVF
[3].
Dilated intradural veins, seen as dilated flow voids on T2
weighted imaging, may be an earlier sign of venous hypertension
and are occasionally seen before venous hypertension causes cord
signal changes. Abnormal intradural vasculature without cord
signal abnormality is usually seen in patients with milder disability,
which is the ideal detection time-point, as greater initial disability
is correlated with poorer outcome [9]. Recently, a case-series has
reported that abnormal flow voids without cord signal changes
have been used to detect essentially incidental SDAVFs, where all
the SDAVFs detected with this isolated sign were asymptomatic
[10]. However, there is overlap between the appearance of flow
voids in SDAVF and the appearance of flow voids in normal
patients [11,12]. Additionally, prior studies evaluating the
diagnostic value of flow voids in patients with SDAVF have
included patients both with flow voids and abnormal cord signal
[7], which when seen together may increase the specificity of the
flow voids in diagnosing SDAVF, as compared to flow voids as an
isolated finding. The purpose of our study was to determine the
prevalence of SDAVF in patients with prominent flow voids as the
only imaging finding suggestive of SDAVF on MR, using catheter
angiography as the gold standard. We further sought to determine
if there were any specific imaging or clinical findings that
distinguished patients with prominent flow voids and positive
angiographic findings from those with a negative angiogram.
Materials and Methods
Ethics Statement
Our institutional review board approved this study, with waiver
of informed consent. All imaging and angiographic examinations
included in this study were performed as standard of care and the
results were retrospectively reviewed.
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Patient Selection and Image Acquisition
We searched our enterprise-wide electronic medical record,
encompassing 20 academic and community hospitals, including a
free-standing pediatric hospital, in an effort to identify patients
who underwent spinal angiography for suspected SDAVF between
January 1, 2005 to March 1, 2012. All spinal angiography reports
were searched using the key-words ‘‘spinal dural arteriovenous
fistula’’, ‘‘SDAVF,’’ ‘‘spinal fistula,’’ ‘‘spinal dural AVF,’’ and
‘‘spinal dural AV fistula,’’. Additionally, MR reports were
searched with the keywords ‘‘dilated vasculature,’’ ‘‘dilated
vessels,’’ ‘‘abnormal vasculature,’’ ‘‘abnormal vessels,’’ ‘‘prominent
flow voids,’’ and ‘‘abnormal flow voids.’’ Patients were excluded if
age was less 18 years, prior cross-sectional imaging or spinal
angiography was not available for review (8 patients), if there was
evidence of spinal pathology other than a SDAVF on imaging
excluding minor degenerative findings based upon review by a
fellowship-trained neuroradiologist both with certificates of added
qualification (2 patients with hypervascular metastases), or
angiography was performed more than 30 days after cross-
sectional imaging (1 patient). Pediatric patients were not included
in this study, as the pathology of spinal vascular malformations in
children is significantly different than in the adult population,
consisting of vascular malformations both with and without a
nidus and are often associated with syndromes such as Weber-
Osler-Rendu, Parkes Weber, Klippel-Trenaunay, and Cobb
syndrome [13]. Additionally patients were excluded if there were
other imaging findings of SDAVF including cord hyperintensity,
enhancement, or expansion based upon review by a fellowship-
trained CAQ certified neuroradiologist (30 patients). At our
institution, MR examinations of the spine are interpreted by
fellowship-trained neuroradiologists. Although the current study
was a retrospective review, the determination of prominent
vasculature for this study utilized the prospective interpretation
by the initial interpreting neuroradiologist. Demographic data
collected included age and sex. Clinical data collected included
presenting symptoms, imaging and angiography results, and post-
imaging clinical management.
MR examinations were performed on a 1.5T system (GE
Healthcare, Milwaukee, Wisconsin) with neutral positioning using
a standard spine coil. Sagittal sequences were obtained with 24 cm
FOV and 2566192 matrix for the cervical and lumbar spines and
a 32 cm FOV and 5126224 matrix for the thoracic spine as
follows: sagittal spin echo T1-weighted (TR, 500 msec; TE, min;
section thickness, 3 mm; number of acquisitions, 3), sagittal fast
spin echo T2-weighted fat saturation (TR, 3500 msec; TE, 84-102
msec; section thickness, 3 mm; number of acquisitions, 3). Axial
images were obtained with 22 cm FOV and 2566192 matrix for
the cervical and lumbar spine and 24 cm FOV and 2566224
matrix for the lumbar spine as follows: axial spine echo T1-
weighted (TR, 500 msec; TE, min; section thickness, 3 mm;
number of acquisitions, 2), fast spin echo T2-weighted images (TR,
3500; TE 102–120 msec; section thickness, 3mm; number of
acquisitions, 2). Additional axial 3D gradient echo images (TR, 35
msec; TE, 13 msec; flip angle 5; section thickness, 2 mm; number
of acquisitions, 1) were obtained with a 22 cm FOV and 2566192
matrix in the cervical spine. If contrast enhanced T1-weighted
images were obtained, post-contrast imaging was performed with
0.1 mmol/kg gadolinium-based contrast material (Multihance:
Bracco, Milan, Italy) using typical T1-weighted parameters as
described above. At our institution, post contrast imaging of the
spine is performed immediately (,1 minute) after contrast
administration.
Digital subtraction angiograms were performed within 30 days
of the MR examinations. At our institution, the standard protocol
is to inject all segmental arteries from the level of the vertebral
arteries to the level of the internal iliac arteries. Segmental arteries
were injected with approximately 3 cc of iohexol (Omnipaque, GE
Healthcare, Milwaukee, Wisconsin; 300 mg of iodine/mL).
Images were obtained at a rate of 2–4 frames/sec with a
102461024 matrix. Identification of the anterior spinal artery
occurred in all cases. All segmental arteries were selectively
catheterized and injected in all patients.
Image Analysis
All MR examinations that were prospectively interpreted by a
fellowship-trained neuroradiologist as having prominent vascula-
ture were re-reviewed in consensus by 2 additional fellowship-
trained, neuroradiologists with certificates of additional qualifica-
tion and more than 2 years of experience. Images were re-
evaluated for findings that have previously been found to be
suggestive of abnormal vasculature on conventional imaging
[11,14,15,16]: (1) flow voids spanning more than 3 vertebral body
levels; (2) serpentine appearance of the vessels; (3) largest size .
2 mm; (4) detection of more than two vessels. Inter-rater
agreement for these imaging findings was determined utilizing
Cohen’s kappa: two fellowship-trained neuroradiologists were
separately asked to determine the presence or absence of each of
the four imaging findings indicative of abnormal vasculature for
each study, blinded to both the clinical and angiographic findings
as well as the other’s interpretation. Kappa results were
interpreted according to Altman (1.0 = perfect agreement, 0.80–
0.99= very good agreement, 0.60–0.79= good agreement, 0.40–
0.59= moderate agreement, 0.20–0.39= fair agreement, and less
than 0.20= poor agreement) [17]. Studies were then scored in
consensus by the two neuroradiologists using these findings and
given 1 point for each finding, for a maximum total score of 4.
Additonally, the number of vertebral body levels spanned by any
abnormal vasculature was recorded.
Data Analysis
Comparison of proportions in the demographic and imaging
analysis data was performed using Fisher’s exact test. Comparison
of continuous variables in the demographic and imaging analysis
data was performed with a two-tailed unpaired t-test. Confidence
intervals for the prevalence were calculated using the interval
estimation for a binomial proportion [18]. Comparison of the
number of vertebral body levels spanned by the abnormal
vasculature between patients with and without SDAVF was
performed with a two-tailed unpaired t-test. P values were two-
tailed and p values less than 0.05 were considered significant.
Results
18 patients (8 male, 10 female; mean age 49 years, range 2–88)
underwent spinal angiography for suspected SDAVF with
prominent flow voids as the only relevant imaging finding
suggestive of SDAVF. The majority of patients presented with
back pain (12 patients, 67%); three patients presented with
myelopathy (17%).
Inter-rater agreement for the finding of flow voids spanning
more than 3 vertebral body levels was perfect (kappa = 1.0, 95%
CI 1.00–1.00), while agreement was very good for determining
serpentine appearance of the vessels (kappa = 0.83, 95% CI 0.65-
1.00) or the detection of more than two vessels (kappa = 0.89, 95%
CI 0.74-1.00). Inter-rater agreement was good for the finding of
largest size .2 mm (0.67, 95% CI 0.43–0.99). The average score
for imaging findings suggestive of abnormal vasculature in these
patients was 2.4 (median 2, range 1–4). Ten patients had abnormal
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vessels spanning more than 3 vertebral levels (56%); eleven had
serpentine vessels (61%); only six had vessels greater than 2 mm in
size (33%); and the large majority had more than 2 vessels detected
(16 patients, 89%). Demographic and clinical characteristics are
summarized in Table 1.
Three patients had a spinal angiogram positive for a SDAVF
(1 male, 2 females; mean age 46.3, range 39–53). All three patients
had type 1 SDAVF according to the Ansler and Spetlzer criteria
[19] and were treated with embolization without findings of
residual SDAVF on subsequent catheter angiography.
The prevalence of SDAVF in our population with only
prominent flow voids was 17% (95% CI 6-39%). Figure 1 shows
a comparison of images between three patients with prominent
flow voids on MR, one with a positive angiogram and two without
findings on angiography.
Of the 15 patients with negative angiography results, seven
continued to be followed for non-specific back pain by a primary
care physician. Presenting symptoms were ascribed to intracranial
pathology without spinal involvement in three patients (1
melanoma brain metastases, 1 multiple sclerosis, and 1 normal
pressure hydrocephalus). In two patients, the presenting symptom
of pain was felt to be related to diabetic neuropathy and in one it
was attributed to restless legs syndrome. One patient underwent
spinal decompression for epidural lipomatosis as the presumed
etiology of the presenting symptoms. In the remaining patient, the
presenting pain was felt to be related to a prior cervical cord injury
that was not imaged and the patient was treated with an
intrathecal catheter.
There was no significant difference in the demographic
characteristics between patients with and without positive angiog-
raphy findings. Similarly, no significant difference was seen in the
scores for findings suggestive of abnormal vasculature or in the
presence of vessels spanning more than 3 vertebral body levels,
serpentine vessels, vessels larger than 2 mm, or more than 2
detected vessels. The average extent of the abnormal vasculature
between patients with and without SDAVF trended towards, but
did not reach statistical significance (mean number of vertebral
body levels spanned by abnormal vasculature = 6.0 and 3.7, range
1–7 and 4–8, respectively, p = 0.07).
Of note, all three patients with positive angiography findings
had myelopathy present clinically and no patients with a negative
angiogram had clinical myelopathy (p = 0.001). No patients with a
score less than 3 had a positive angiogram. Comparison of the
demographic and imaging data between the two groups is
summarized in Table 2.
Table 1. Demographic and clinical characteristics of patients undergoing myelography with prominent flow voids as the only
imaging finding suggestive of SDAVF.
Patient No. Age Sex Presenting Symptom Angiography Findings
1 39 F Myelopathy1 SDVAF from right T6 and T7 radicular arteries
2 63 F Post-laminectomy syndrome Negative
3 73 M Thoracolumbar pain Negative
4 26 F Back pain Negative
5 27 F Bilateral lower extremity pain Negative
6 43 M Back pain Negative
7 20 F Chiari Malformation Negative
8 63 F Back pain Negative
9 53 F Bilateral lower extremityweakness, myelopathy2 SDVAF arising from the left L1 radicular artery
10 51 F Lower extremity pain Negative
11 60 M Back pain Negative
12 59 M Back pain Negative
13 45 M Back pain Negative
14 42 F Back pain Negative
15 64 M Bilateral lower extremity pain Negative
16 60 M Back pain Negative
17 88 F Back pain Negative
18 47 M Back pain and myelopathy3 SDVAF arising from the right T12 radicular artery
1Myelopathic symptoms of progressive loss of strength and sensation in the lower extremities.
2Myelopathic symptoms of urinary retention and constipation.
3Myelopathic symptoms of abnormal sensation in the lower extremities.
doi:10.1371/journal.pone.0099004.t001
Figure 1. Abnormal flow voids without cord signal are seen in
both patients with and without SDAVF. Sagittal T2-weighted
images show prominent flow voids in (a) a patient with a positive spinal
angiogram (arrows) and (b) a patient with negative angiography results
(triangular arrowheads).
doi:10.1371/journal.pone.0099004.g001
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Discussion
Prominent flow voids without other imaging findings of SDAVF
were found to be poorly predictive of the presence of a SDAVF,
unless myelopathy was present clinically. No patients with less
than three of the four imaging findings previously found to be
suggestive of abnormal vasculature had a positive angiogram.
Previous studies evaluating the value of flow voids in the
diagnosis of SDAVF have included patients with both flow voids
and abnormal cord signal [3,7,10,20], therefore obscuring the
value of this finding in isolation. A recent study has indicated the
importance of suggesting the diagnosis of SDAVF in the setting of
prominent flow voids, even in the absence of other imaging
findings suggestive of SDAVF or myelopathic symptoms, given the
possibility of detecting a SDAVF before it becomes symptomatic
[10]. However, this study only retrospectively evaluated patients
with positive angiographic findings and did not evaluate the
prevalence of prominent flow voids in patients with negative
angiographic studies. Thus, radiologists have been left with the
impression that they may potentially miss a curable spinal
myelopathy if SDAVF is not routinely mentioned in the setting
of prominent flow voids. However, our results would suggest such
an approach would result in a very high number of false positive
studies. False positives are significant in the workup of a SDAVF,
as they can result in catheter angiography, which has significant
risks, even in the hands of experienced practitioners, as well as the
potential for nephrotoxicity associated with use of iodinated
contrast [3].
Our study is the first to evaluate for SDAVF in all patients with
prominent vasculature as the only finding of SDAVF on
conventional imaging, with catheter angiogram for definitive
diagnosis. Previous studies examining prominent flow voids
without abnormal cord signal have only evaluated its value in
populations with known SDAVFs [10,21]. No study has yet
evaluated this finding in the general population to determine its
associated false positive rate for diagnosing a SDAVF. In
contradistinction to the prior case series [10], we did not find
any patients with a SDAVF with only prominent flow voids on
imaging and without myelopathy on clinical examination. The
presence of myelopathy without abnormal cord signal in our
patients may reflect venous hypertension high enough to cause
decreased cord perfusion and myelopathy, but not substantial or
long-standing enough to cause edema and abnormal cord signal
[3]. This correlates with the known lack of association between
cord signal and symptoms after treatment of the SDAVF [22].
Lack of both abnormal cord signal and myelopathy suggests the
prominent vasculature does not reflect venous hypertension but
rather anatomic variation, except perhaps in rare, reportable cases
[10]. Therefore, in patients with prominent vascular flow voids but
no abnormal cord signal, given the relative rarity of SDVAF in this
population, correlation for a history of myelopathy should be
undertaken.
None of the patients with less than three of the four imaging
findings previously found to be suggestive of abnormal vasculature
had a SDAVF. The presence of any one of the four findings may
result in a subjective appearance of prominent vasculature on
imaging. However, based on our findings, we would advise that
determination of abnormal vasculature should not be based on a
simple overall impression, which may be influenced by only one or
two of the flow void findings. Rather, if there is a suspicion that the
vasculature may be abnormal, a dedicated evaluation for the
known four imaging findings of flow voids in SDAVF should be
undertaken as well as a search of the medical record, or discussion
with the referring physician, for a history of myelopathy.
Additionally, a further workup to assess for subtle myelopathic
findings on physical examination or subtle imaging findings of a
SDAVF, including possible MR angiography, may be helpful [23].
Furthermore, a higher number of vertebral body levels spanned by
the abnormal vasculature showed a trend towards significance,
and has previously been correlated with the degree of myelopathy
in patients with SDAVF [24]. Larger studies may be helpful to
confirm this finding as a way to determine truly abnormal
vasculature.
The principal limitation to this study is that our institution does
not routinely perform spinal MR angiograms (spinal MRA).
While, spinal MRA has emerged as a useful, noninvasive, tool in
which to localize arterial feeders and venous drainage patterns in
patients with high clinical imaging suspicion for, and corroborative
imaging findings strongly suggestive of, SDAVF [25,26], it has not
been shown to improve sensitivity or specificity in detection of
SDAVF in patients with equivocal conventional MR findings, such
as lack of abnormal cord signal [11]. As a result, our spinal
angiographers, believe that spinal MRA, in patients with such
equivocal MR findings, to be of insufficient negative predictive
value to preclude spinal angiography, and hence do not routinely
order them in this subset of patients.
Additional limitations of this study include its retrospective
nature and small sample size. However, SDAVF itself is a rare
disease, and prominent flow voids and lack of abnormal T2 signal
is an even rarer imaging presentation of the disease [9,25,26]. In
Table 2. Comparison of demographic and imaging data for patients with and without positive findings on angiography.
Patients with Negative Angiogram Patients with Positive Angiogram p value
Number 15 3 N/A
Number male (%) 7 (47%) 1 (33%) 0.6
Age (yrs, mean, range) 49.7 (20–88) 46.3 (39–53) 0.61
Score for findings suggesting abnormal vessels
(mean, range)
2.2 (1–4) 3.3 (3–4) 0.2
Vessels spanning more than 3 levels (number, percent) 7 (47%) 3 (100%) 0.22
Serpentine vessels (number, percent) 8 (53%) 2 (66%) 1
Vessel .2 mm size (number, percent) 5 (33%) 2 (66%) 0.53
Detection of more than 2 vessels (number, percent) 13 (87%) 3 (100%) 1
Presence of myelopathy (number, percent) 0 (0%) 3 (100%) 0.001
doi:10.1371/journal.pone.0099004.t002
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selecting for patients only with a definitive angiographic study, we
further decreased our potential patient population, as it rare to
undertake invasive angiography with only a single imaging finding.
However, we feel that this further strengthens our finding, as the
patients included in our study underwent angiography either
because the radiologist felt very strongly about the flow void
appearance or there was strong clinical concern. The poor
correlation between flow voids and SDAVF in this population with
either high imaging confidence or clinical suspicion further
supports that prominent flow voids without cord signal abnormal-
ity should not be considered abnormal on a routine basis.
Conclusion
In conclusion, the prevalence of SDAVF in patients with
prominent flow voids as the only imaging finding suggestive of
SDAVF is low, particularly in patients without myelopathy and in
those with less than three imaging findings to suggest abnormal
vasculature.
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